![Automated closed-loop control of diabetes: the artificial pancreas | Bioelectronic Medicine | Full Text Automated closed-loop control of diabetes: the artificial pancreas | Bioelectronic Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs42234-018-0015-6/MediaObjects/42234_2018_15_Fig1_HTML.png)
Automated closed-loop control of diabetes: the artificial pancreas | Bioelectronic Medicine | Full Text
![Figure 1 from Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions | Semantic Scholar Figure 1 from Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a29b57f940517cbc5d3062983b1d05bb0089cd21/2-Figure1-1.png)
Figure 1 from Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions | Semantic Scholar
![Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6–12 years: a randomised, controlled, cross-over, non-inferiority trial - The Lancet Digital Health Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6–12 years: a randomised, controlled, cross-over, non-inferiority trial - The Lancet Digital Health](https://www.thelancet.com/cms/attachment/31ab2e41-de82-46ba-bf47-7bbc7aa60083/gr1.gif)
Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6–12 years: a randomised, controlled, cross-over, non-inferiority trial - The Lancet Digital Health
![Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study](https://bmjopen.bmj.com/content/bmjopen/11/2/e042790/F1.large.jpg)
Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study
Suboptimal kontrollierter Typ-1-Diabetes: Hybrid-Closed-Loop-System reduziert vor allem das Risiko für Hypoglykämien
![Closed Loop: Die Hoffnung für Menschen mit Diabetes - Gesundheit - derStandard.de › Wissen und Gesellschaft Closed Loop: Die Hoffnung für Menschen mit Diabetes - Gesundheit - derStandard.de › Wissen und Gesellschaft](https://i.ds.at/MWydyw/rs:fill:493:0/plain/2021/08/22/CUR210824-Seite-40-Rondo.jpg)